Alafair Biosciences, Inc.
PrivateLast Round
Series B
Apr 18, 2019
Total Funding Raised
$14.26M
Company Overview
Alafair Biosciences, Inc. operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Series B round in April 2019.
Alafair Biosciences, Inc. is a medical device company that develops and commercializes a portfolio of products based on its proprietary hydrogel technology designed to improve patient outcomes by enhancing internal wound healing and protecting soft tissues after surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alafair Biosciences, Inc. Comparables
Compare Alafair Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TYBR Health | 87% | |
| MAST Biosurgery AG | 83% | |
| FzioMed, Inc. | 81% |
For institutional investors. Book with your work email.
Alafair Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 18, 2019 | ||||
| VC Round | Oct 19, 2018 | ||||
| Convertible Debt | Jul 19, 2017 | ||||
| Series A | Aug 10, 2016 | ||||
| Grant | May 16, 2014 | ||||
Seed | Sep 10, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alafair Biosciences, Inc. Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2025
Ranked #2 on the 2025 Longhorn 100 list.
- Aug 10, 2016
$2M round led by ATP Fund.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asAug 11, 2026
Inc. names Alafair Biosciences, Inc. to its 2026 Inc. 5000 ranking of America’s fastest-growing private companies for the fourth consecutive year, announced in Texas on Aug 11th '26.
For institutional investors. Book with your work email.
Alafair Biosciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alafair Biosciences, Inc.'s valuation, stock price, and market status.
Is Alafair Biosciences, Inc. a public or private company?
Alafair Biosciences, Inc. is a private company.
What is the current stock price of Alafair Biosciences, Inc.?
Alafair Biosciences, Inc. is a private company, so its shares have no public market price. Caplight tracks Alafair Biosciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alafair Biosciences, Inc. worth (valuation)?
Valuation information for Alafair Biosciences, Inc. is not publicly available.
Can I buy Alafair Biosciences, Inc. stock?
Alafair Biosciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alafair Biosciences, Inc.'s last funding round?
Alafair Biosciences, Inc.'s most recent funding round was Series B on April 18, 2019.
Who are the main investors in Alafair Biosciences, Inc.?
Key investors in Alafair Biosciences, Inc. include ATP Fund.
Will Alafair Biosciences, Inc. IPO soon?
No public IPO plans have been announced for Alafair Biosciences, Inc..
How can I track Alafair Biosciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Alafair Biosciences, Inc.'s shares on secondary markets.